<DOC>
	<DOCNO>NCT01964131</DOCNO>
	<brief_summary>The purpose study ; To investigate whether D961H sachet 20 mg bioequivalent D961H HPMC capsule 20 mg assessment percentage time intragastric pH &gt; 4 . To compare D961H sachet 20 mg D961H HPMC capsule 20 mg assessment percentage time intragastric pH &gt; 3 24 hour 24-hour median pH . To compare PK property D961H sachet 20 mg D961H HPMC capsule 20 mg. To evaluate safety tolerability D961H sachet 20 mg D961H HPMC capsule 20 mg .</brief_summary>
	<brief_title>BE Study Between Capsule Sachet Formulation D961H Pharmacodynamics Japanese Healthy Male Subjects</brief_title>
	<detailed_description>The purpose study ; To investigate whether pellet base sachet formulation D961H 20 mg ( D961H sachet 20 mg ) bioequivalent commercial HPMC capsule D961H 20 mg ( D961H HPMC capsule 20 mg ) repeat oral dos assessment percentage time intragastric pH &gt; 4 24 hour dose Day 5 . To compare D961H sachet 20 mg D961H HPMC capsule 20 mg repeat oral dos assessment percentage time intragastric pH &gt; 3 24 hour 24-hour median pH dose Day 5 To compare PK property D961H sachet 20 mg D961H HPMC capsule 20 mg repeat oral dos assessment AUCÏ„ , Cmax , s , AUC0-t , s , MRT , tmax , s , t1/2 , ss esomeprazole dose Day 5 . To evaluate safety tolerability D961H sachet 20 mg D961H HPMC capsule 20 mg assessment adverse event , clinical laboratory test , blood pressure ( BP ) , pulse rate body temperature .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Provision sign date , write informed consent prior study specific procedure Healthy Japanese male subject 20 45 year age Body Mass Index ( BMI=weight/height2 ) 1927 ( kg/m2 ) Body weight 5085 kg Negative HIV antigen/antibody , Hepatitis B surface antigen , Hepatitis C antibody syphilis Clinically normal finding enrolment medical examination , judge investigator ( ) HomoEM accord genotype CYP2C19 Less 30 % time intragastric pH &gt; 4 baseline ( preentry ) 24hr intragastric pH record Helicobacter pylori negative know urea breath test volunteer panel data Significant clinical illness 2 week precede preentry visit randomisation , judge investigator ( ) , eg , acute inflammatory disease require medical intervention Past present cardiac , renal , hepatic , neurological gastrointestinal disease , judge investigator ( ) , eg , sequelae myocardial infarction , nephritis , hepatitis cerebral infarction Past present drug addiction alcohol abuse Past present severe allergic disease , hypersensitivity food drug ( except seasonal hay fever ) , allergic symptom require medical intervention Moderate heavy smoking sort nicotine use ( great 10 cigarette per day correspond nicotine use ) Clinical significant condition could modify absorption investigational product , judge investigator ( ) , eg , effect absorption investigational product diarrhoea , history excision part stomach Donation blood excess 200 mL 1 month , excess 400 mL 3 month excess 1200 mL 12 month first dose treatment period 1 ( include blood component donation ) Need concomitant medication study Use prescribe medication 2 week precede preentry visit randomisation , counter ( OTC ) drug ( include herb , vitamins mineral ) one week precede preentry visit randomisation , unless approve investigator ( ) sponsor Use grapefruit grapefruit juice , health food contain St. John 's wort consumption within 2 week prior first dose treatment period 1 Administration investigational product within 4 month precede preentry visit Involvement plan conduct study ( applies AstraZeneca staff staff study site ) Clinical judgment investigator ( ) subject participate study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>D961H</keyword>
	<keyword>Japanese</keyword>
</DOC>